- Report
- October 2022
- 220 Pages
United States
From €4490EUR$5,000USD£3,846GBP
- Report
- March 2018
- 100 Pages
United States
From €2155EUR$2,400USD£1,846GBP
- Report
- May 2024
- 607 Pages
Global
From €2955EUR$3,290USD£2,531GBP
- Report
- July 2023
- 270 Pages
Global
From €4445EUR$4,950USD£3,807GBP
- Report
- April 2024
- 115 Pages
United States
From €1617EUR$1,800USD£1,385GBP
- Report
- October 2023
- 377 Pages
Global
From €3772EUR$4,200USD£3,231GBP
- Report
- June 2022
- 358 Pages
Global
From €3143EUR$3,500USD£2,692GBP
- Report
- March 2024
- 202 Pages
Global
From €4445EUR$4,950USD£3,807GBP
- Report
- December 2023
- 82 Pages
Europe
From €1325EUR$1,475USD£1,135GBP
€2649EUR$2,950USD£2,269GBP
- Report
- April 2024
- 121 Pages
Global
From €4176EUR$4,650USD£3,577GBP
- Report
- July 2023
- 152 Pages
Global
From €4176EUR$4,650USD£3,577GBP
- Report
- March 2021
- 345 Pages
Global
From €2470EUR$2,750USD£2,115GBP
- Report
- March 2024
- 162 Pages
Global
From €4445EUR$4,950USD£3,807GBP
- Report
- January 2024
- 69 Pages
Asia Pacific
From €2649EUR$2,950USD£2,269GBP
- Report
- July 2023
- 325 Pages
Global
From €2470EUR$2,750USD£2,115GBP
€4939EUR$5,500USD£4,230GBP
- Report
- July 2023
- 166 Pages
Global
From €2470EUR$2,750USD£2,115GBP
€4939EUR$5,500USD£4,230GBP
- Report
- May 2022
- 170 Pages
Middle East
From €2357EUR$2,625USD£2,019GBP
€4715EUR$5,250USD£4,038GBP
- Report
- October 2021
- 292 Pages
Global
From €4984EUR$5,550USD£4,269GBP
- Report
- July 2021
- 106 Pages
Global
From €4984EUR$5,550USD£4,269GBP
- Report
- May 2023
- 150 Pages
Global
From €5344EUR$5,950USD£4,577GBP

The biopsy market within the context of In Vitro Diagnostics (IVD) is a segment of the healthcare industry that focuses on the diagnosis of diseases and conditions through the analysis of biological samples. Biopsy tests are used to detect a wide range of conditions, including cancer, infections, and autoimmune diseases. The biopsy market is composed of a variety of products and services, including biopsy needles, biopsy forceps, biopsy punches, and biopsy kits. These products are used to collect tissue samples from patients for further analysis.
The biopsy market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of advanced technologies. Additionally, the increasing adoption of minimally invasive procedures and the rising demand for cost-effective diagnostic solutions are expected to drive the growth of the biopsy market.
Some of the major companies in the biopsy market include Becton Dickinson, Cook Medical, Olympus Corporation, Stryker Corporation, and Hologic Inc. Show Less Read more